FDA finds ‘no evidence’ that second Pfizer pill stops repeat COVID-19 symptoms
“While Pfizer’s COVID-19 antiviral Paxlovid does offer a reduction in hospitalization and deaths, there is currently “no evidence” to suggest that prolonging and repeating a course of the drug has any more benefit, according to an FDA official.” - Joseph Choi